CLOSING THE WINDOW OF TIME BETWEEN INFECTION AND DETECTION
Reducing the time to detect infectious diseases and cancers is the main focus of the diagnostics industry. The earlier a test can be detected, the more favorable the outcome for the patient because they can be treated before the disease progresses beyond help.
MRN Diagnostics can help you design and validate your cutting-edge diagnostic.
DIAGNOSTIC
DESIGN AND DEVELOPMENT
MRNDx partners globally with diagnostic developers and manufacturers to optimize and validate the performance of their tests. MRN supports the development of: rapid point-of-care, serology, antigen and molecular testing platforms. By providing
precise clinical specimens and certified analytical service testing, MRN is able to accelerate your development pipeline. To complement this MRN also provides OEM kit control design, development, validation and GMP and ISO 13485:2016 compliant manufacturing. All of MRN liquid and swab controls are ready to use, noninfectious with room temp or refrigerated stability for antibody, antigen and molecular testing platforms.
DIAGNOSTIC DEVELOPMENT
PRODUCT PIPELINE
PRODUCT FEASIBILITY
DEFINING PERFORMANCE SPECIFICATIONS AND MANUFACTURING REQUIREMENTS FOR YOUR DIAGNOSTIC PRODUCT
At MRN Diagnostics, we work with your development team to determine the feasibility of producing your diagnostic product. This is the first step in our Design, Development and Manufcturing Product Pipeline. We begin by examining the requirements for developing, validating and manfacuring your product for commercial sucess. This assessment examines your companies capabilities prior to development work to guarantee that your product is designed and manufactured manufactured within the capabilities of your organization while also meeting the needs of the commercial marketplace.
